Ulla Helena Danielson
Founder at Beactica Therapeutics AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rajeev Ahuja | M | - |
University of Uppsala
| - |
| Anders R. Hallberg | M | 79 |
University of Uppsala
| 6 years |
| Per Källblad | M | - |
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 18 years |
| Sverker Ljunghall | M | - |
University of Uppsala
| - |
| Håkan Gunnar Engqvist | M | 52 |
University of Uppsala
| - |
| Carl-Hendrik Heldin | M | 72 |
University of Uppsala
| 32 years |
| Margareta Elisabeth Björk | M | 63 |
University of Uppsala
| - |
| Angelica Loskog | M | 51 |
University of Uppsala
| - |
| Gullik Håkan Wickholm | M | 65 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 6 years |
| Ulf Bremberg | M | - |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 9 years |
| Johan Lindh | M | - |
University of Uppsala
| 10 years |
| Ulf Bertil Olof Göransson | M | 54 |
University of Uppsala
| - |
| Lars Thomander | M | 77 |
University of Uppsala
| - |
| Bengt Westermark | M | 79 |
University of Uppsala
| 38 years |
| Jarl Ulf Birger Jungnelius | M | 73 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 1 years |
| Maarten de Château | M | 61 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 5 years |
| Hilpi Rautelin | M | 63 |
University of Uppsala
| 16 years |
| Eva Ursula Hultqvist Bengtsson | M | 64 |
University of Uppsala
| - |
| Peter von Ehrenheim | M | 69 |
University of Uppsala
| - |
| Per Gunningberg | M | 71 |
University of Uppsala
| - |
| Ingemar Kihlström | M | 72 |
University of Uppsala
| - |
| Marie-Louise Fjaellskog | M | 59 |
University of Uppsala
| 16 years |
| Niklas Dahl | M | - |
University of Uppsala
| 24 years |
| Magnus Essand | M | 60 |
University of Uppsala
| 15 years |
| Anne Ramberg | F | - |
University of Uppsala
| - |
| Per Matsson | M | 70 |
University of Uppsala
| - |
| Johan Olof Kämpe | M | 68 |
University of Uppsala
| 25 years |
| Karl Johan Anders Wall | M | 60 |
University of Uppsala
| - |
| Mathias Hallberg | M | 53 |
University of Uppsala
| - |
| Rolf Larsson | M | - |
University of Uppsala
| - |
| Rolf Larsson | M | - |
University of Uppsala
| - |
| Gustav Ingemar Kihlström | M | 71 |
University of Uppsala
| - |
| Jan Thorell | M | - |
University of Uppsala
| - |
| Erik Walldén | M | 75 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 7 years |
| Marek Kwiatkowski | M | 74 |
University of Uppsala
| - |
| Alf Gunnar Martin Nicklasson | M | 69 |
University of Uppsala
| - |
| Jonas Göran Ekblom | M | 59 |
University of Uppsala
| - |
| Bengt Gerdin | M | 77 |
University of Uppsala
| 30 years |
| Margot Gunilla Fransson | M | 64 |
University of Uppsala
| - |
| Nils Martin Malmsten | M | - |
University of Uppsala
| - |
| Ernst Åke Bertil Karlmark | M | 86 |
University of Uppsala
| - |
| Mats Bo Johan Nilsson Bernitz | M | 54 |
University of Uppsala
| 21 years |
| Lars Ture Pettersson | M | 70 |
University of Uppsala
| - |
| Lars Harald Baltzer | M | 73 |
University of Uppsala
| - |
| Johan Stenberg | M | - |
University of Uppsala
| - |
| Claes Tomas Post | M | 74 |
University of Uppsala
| 36 years |
| Gisela Marie Sitbon | M | 66 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | - |
| Anders Wilhelmson | M | - |
University of Uppsala
| - |
| Andreas Waber | M | - |
University of Uppsala
| - |
| Knut Lars Carl Wiklund | M | 81 |
University of Uppsala
| - |
| Lars Bohlin | M | 76 |
University of Uppsala
| - |
| Bo Walter Wennström | M | 70 |
University of Uppsala
| - |
| Per Christer Folke Lundberg | M | 81 |
University of Uppsala
| - |
| Ingrid Westin Wallinder | F | 67 |
University of Uppsala
| - |
| Jonas Rastad | M | 74 |
University of Uppsala
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Ketema | M | - |
University of Uppsala
| 6 years |
| Andreas Ueno-Olausson | M | - |
University of Uppsala
| 6 years |
| Alex Basu | M | - |
University of Uppsala
| 9 years |
| Jamal Abisourour | M | - |
University of Uppsala
| 1 years |
| Stefan Knutsson | M | - |
University of Uppsala
| 6 years |
| Anders Johansson | M | 48 |
University of Uppsala
| 3 years |
| Joachim Carlsson | M | - |
University of Uppsala
| 4 years |
| Iliam Barkino | M | - |
University of Uppsala
| 5 years |
| Charbel Altunkaynak | M | - |
University of Uppsala
| 5 years |
| Arno Niazi | M | - |
University of Uppsala
| 4 years |
| Olof Löfving | M | - |
University of Uppsala
| 5 years |
| Stina Wallmark | F | - |
University of Uppsala
| 7 years |
| Magnus Sjöcrona | M | - |
University of Uppsala
| 6 years |
| Erika Ekberger | F | - |
University of Uppsala
| 30 years |
| Oscar Östlin | M | - |
University of Uppsala
| 4 years |
| Rasmus Davidsson | M | 39 |
University of Uppsala
| 4 years |
| Caroline Lundgren Brandberg | F | 45 |
University of Uppsala
| 1 years |
| Andreas Wagner | M | - |
University of Uppsala
| 2 years |
| Karl Svensson | M | 47 |
University of Uppsala
| 2 years |
| Malin Lundgren | F | 46 |
University of Uppsala
| 4 years |
| Kajsa Gustafsson | F | - |
University of Uppsala
| 4 years |
| Karin Göransson | F | 45 |
University of Uppsala
| 5 years |
| Viktor Berglind | M | - |
University of Uppsala
| 4 years |
| Girish Ganesan | M | - |
University of Uppsala
| 4 years |
| Robin Flodin | M | 37 |
University of Uppsala
| 4 years |
| Carl Gustav Fritjofsson | M | - |
University of Uppsala
| 5 years |
| Erik Hultgård | M | - |
University of Uppsala
| 1 years |
| Martin Ragnar Andersson | M | 45 |
University of Uppsala
| 4 years |
| Carl Johan Olof Merner | M | 49 |
University of Uppsala
| 2 years |
| Ulrich Heinle | M | - |
University of Uppsala
| 3 years |
| Mats Gullberg | M | 53 |
University of Uppsala
| 3 years |
| Jonas Sven Peter Jarvius | M | 53 |
University of Uppsala
| 3 years |
| Sten-Magnus Aquilonius | M | 85 |
University of Uppsala
| 10 years |
| Gustaf Peter Torgny Karling | M | 52 |
University of Uppsala
| 5 years |
| Simon Tor Angeldorff | M | - |
University of Uppsala
| 9 years |
| Lars Christer Nyström | M | 73 |
University of Uppsala
| 19 years |
| Kirk L. Williams | M | - |
University of Uppsala
| 3 years |
| Rolf Magnus Björsne | M | 60 |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | 4 years |
| Kristina Medin | F | - |
University of Uppsala
| 4 years |
| Markus Kitunen | M | - |
University of Uppsala
| 5 years |
| Monika Pers | F | 40 |
University of Uppsala
| 2 years |
| Carl Magnus Nikolaus Brandberg | M | 44 |
University of Uppsala
| 5 years |
| Torsten Brandberg | M | 44 |
University of Uppsala
| 6 years |
| Therese Lundstedt | F | 43 |
University of Uppsala
| 4 years |
| Daniel Althoff | M | - |
University of Uppsala
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ulla Helena Danielson
- Personal Network
